HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bristol-Myers Squibb

This article was originally published in The Rose Sheet

Executive Summary

Consumer products sales gained 1% in the second quarter, excluding the effect of divested businesses. The firm pointed to strong performance by its Clairol segment, highlighting growth by the Nice 'n Easy and Lasting Color by Loving Care brands in the U.S. Consolidated worldwide sales increased 6% to $2.97 bil. in the second quarter and were up 4.4% to $5.8 bil. in the half. Net earnings grew 4.1% to $542 mil. in the quarter and rose 2.5% to $1.12 bil. in the half

Consumer products sales gained 1% in the second quarter, excluding the effect of divested businesses. The firm pointed to strong performance by its Clairol segment, highlighting growth by the Nice 'n Easy and Lasting Color by Loving Care brands in the U.S. Consolidated worldwide sales increased 6% to $2.97 bil. in the second quarter and were up 4.4% to $5.8 bil. in the half. Net earnings grew 4.1% to $542 mil. in the quarter and rose 2.5% to $1.12 bil. in the half.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000673

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel